Cogstate jumps 51pc on Alzheimer’s drug news

MELBOURNE: Shares in Cogstate, a neuroscience technology company backed by the Myer family, rocketed 60… read more

New Alzheimer’s drug unlikely to be approved in Australia

CANBERRA: A controversial new drug that has offered hope to Alzheimer’s sufferers by slowing cognitive… read more

Regulator approves first new Alzheimer’s drug in 20 years

NEW YORK: US firm Biogen was in the headlines this morning after regulators approved the… read more

George Razay to bring dementia lecture to Launceston June 5

LAUNCESTON: The groundbreaking research of Launceston physician George Razay has already changed the way doctors… read more